Susquehanna International Group
TSVT

Susquehanna International Group’s 2seventy bio TSVT Stock Holding History

Susquehanna International Group’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-81,400
Closed -$384K – 13255
2024
Q3 		$384K Buy
+81,400
New +$367K ﹤0.01% 9078
2024
Q2 		– Sell
-43,900
Closed -$235K – 13264
2024
Q1 		$235K Sell
43,900
-4,100
-9% -$19.3K ﹤0.01% 10251
2023
Q4 		$205K Buy
+48,000
New +$148K ﹤0.01% 10638
2023
Q3 		– Sell
-35,800
Closed -$362K – 13009
2023
Q2 		$362K Buy
+35,800
New +$379K ﹤0.01% 9056
2022
Q4 		– Sell
-37,700
Closed -$549K – 13703
2022
Q3 		$549K Buy
+37,700
New +$560K ﹤0.01% 8241

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Susquehanna International Group's TSVT Position: Q2 2025 in Review

Susquehanna International Group sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 180,057 shares — an estimated $889K sold.

Susquehanna International Group first reported a position in TSVT in Q4 2021 and held it in 13 quarters. The position peaked at $2.38M in Q4 2021. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Susquehanna International Group reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 180,057 2seventy bio shares in Q2 2025, an estimated $889K.
  • Susquehanna International Group first reported a position in 2seventy bio in Q4 2021 and held it in 13 quarters.
  • Susquehanna International Group's 2seventy bio position peaked at $2.38M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.